MICs of eight antibiotics were detected with 40 Chinese Mycoplasma pneumoniae isolates. Thirty-eight isolates (95%) were macrolide resistant. Each macrolide-resistant isolate harbored an A2063G or A2064G point mutation in the 23S rRNA gene. All 40 isolates (100%) were type I strains, but they might have originated from different clones.
Mycoplasma pneumoniae is a common pathogen causing community-acquired pneumonia (CAP) (4, 9, 12). Macrolides are the drugs of primary choice for the treatment of M. pneumoniae infections. Macrolide resistance rates of M. pneumoniae have increased rapidly in recent years, especially in Asia (3, 10, 11). In 2009, studies from China found that 83% (44/53) and 92% (46/50) of M. pneumoniae strains isolated from pediatric patients in Shanghai (6) and Beijing (14) were resistant to macrolides, respectively. In 2010, the macrolide resistance rate of M. pneumoniae isolated from ambulatory adult patients was 69% (46/67) in Beijing (1).In this study, 40 M. pneumoniae isolates were collected from CAP patients in Beijing, China. The antibiotic resistance patterns of this pathogen were surveyed with eight agents, and the mechanisms of resistance for macrolide-resistant isolates were investigated with 23S rRNA gene analysis.M. pneumoniae strains. Forty M. pneumoniae isolates were obtained from 182 CAP patients in the Beijing, Dongcheng, and Xicheng Centers for Disease Control and Prevention from January 2011 to June 2011. The clonalities of all M. pneumoniae isolates were determined by the filtration-cloning technique and identified by colony morphology and real-time PCR assays (2).Antimicrobial susceptibility testing of isolates. The MICs of eight antibiotics were determined by broth microdilution methods with SP4 broth (Remel). M. pneumoniae reference strain M129 (ATCC 29342) was tested as an antibiotic-sensitive control. Thirty-eight (95%) isolates were macrolide resistant. The MIC 50 values of isolates for erythromycin, clarithromycin, azithromycin, and josamycin were greater than 256 g/ml, 256 g/ml, 32 g/ml, and 4 g/ml, respectively. The MIC 90 values of the isolates with the four macrolides above were greater than 256 g/ml, 256 g/ ml, 32 g/ml, and 8 g/ml, respectively. All M. pneumoniae isolates were susceptible to tetracycline and fluoroquinolones (Table 1). Gatifloxacin was more active than ciprofloxacin and levofloxacin. The MIC 90 of gatifloxacin (0.064 g/ml) was much lower than those of ciprofloxacin (1 g/ml) and levofloxacin (1 g/ml).Sequencing analysis of the 23S rRNA gene. Genomic DNA of each isolate was extracted with the QIAamp DNA minikit (Qiagen). Domains II and V of the 23S rRNA gene were amplified by methods described previously (8). All the amplicons were sequenced by the Beijing Genomics Institute (BGI). Thirty-seven isolates harbored an A2063G mutation in domain V of the 23S rRNA gene, while one isolate harbored an A2064G mutation in domain V of the 23S rRNA gene. No mutations were found in domain II (Table 1).Typing of the p1 gene. All 40 M. pneumoniae isolates from CAP...